Compile Data Set for Download or QSAR
maximum 50k data
Found 165 Enz. Inhib. hit(s) with all data for entry = 6489
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM132064(US8841455, 159)
Affinity DataIC50:  18.5nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM132046(US8841455, 141)
Affinity DataIC50:  32.7nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM131909(US8841455, 4)
Affinity DataIC50:  42nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM132042(US8841455, 137)
Affinity DataIC50:  54.6nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM131908(US8841455, 3)
Affinity DataIC50:  57.9nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM132028(US8841455, 123)
Affinity DataIC50:  72.8nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM132067(US8841455, 162)
Affinity DataIC50:  74.4nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM132057(US8841455, 152)
Affinity DataIC50:  79.5nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM131983(US8841455, 78)
Affinity DataIC50:  82.5nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM132061(US8841455, 156)
Affinity DataIC50:  86.8nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM132013(US8841455, 108)
Affinity DataIC50:  87.9nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM132065(US8841455, 160)
Affinity DataIC50:  90.4nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM132019(US8841455, 114)
Affinity DataIC50:  91.4nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM131967(US8841455, 62)
Affinity DataIC50:  92.8nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM132068(US8841455, 65 Step D)
Affinity DataIC50:  93.6nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM131968(US8841455, 63)
Affinity DataIC50:  94.7nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM131966(US8841455, 61)
Affinity DataIC50:  95.1nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM132014(US8841455, 109)
Affinity DataIC50:  96.6nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM131943(US8841455, 38)
Affinity DataIC50:  98.3nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM131932(US8841455, 27)
Affinity DataIC50:  101nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM131977(US8841455, 72)
Affinity DataIC50:  102nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM132051(US8841455, 146)
Affinity DataIC50:  102nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM131980(US8841455, 75)
Affinity DataIC50:  107nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM132045(US8841455, 140)
Affinity DataIC50:  108nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM131906(US8841455, 1)
Affinity DataIC50:  112nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM131907(US8841455, 2)
Affinity DataIC50:  118nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM132058(US8841455, 153)
Affinity DataIC50:  118nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM131984(US8841455, 79)
Affinity DataIC50:  120nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM131969(US8841455, 64)
Affinity DataIC50:  122nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM132052(US8841455, 147)
Affinity DataIC50:  123nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM132059(US8841455, 154)
Affinity DataIC50:  132nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM131957(US8841455, 52)
Affinity DataIC50:  135nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM132055(US8841455, 150)
Affinity DataIC50:  136nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM131910(US8841455, 5)
Affinity DataIC50:  137nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM132044(US8841455, 139)
Affinity DataIC50:  138nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM131920(US8841455, 15)
Affinity DataIC50:  138nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM131993(US8841455, 88)
Affinity DataIC50:  141nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM132030(US8841455, 125)
Affinity DataIC50:  141nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM131928(US8841455, 23)
Affinity DataIC50:  141nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM132011(US8841455, 106)
Affinity DataIC50:  141nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM131921(US8841455, 16)
Affinity DataIC50:  145nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM132056(US8841455, 151)
Affinity DataIC50:  149nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM132069(US8841455, 77 Step C)
Affinity DataIC50:  150nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM132016(US8841455, 111)
Affinity DataIC50:  152nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM132029(US8841455, 124)
Affinity DataIC50:  156nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM131994(US8841455, 89)
Affinity DataIC50:  156nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM132032(US8841455, 127)
Affinity DataIC50:  157nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM131979(US8841455, 74)
Affinity DataIC50:  158nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM131995(US8841455, 90)
Affinity DataIC50:  164nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM131986(US8841455, 81)
Affinity DataIC50:  164nMpH: 7.3 T: 2°CAssay Description:The ability of compounds of Formula I to inhibit cFMS was determined by the following assay. cFMS enzymatic activity was measured using the LANCE Ult...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 165 total ) | Next | Last >>
Jump to: